临床外科杂志 ›› 2019, Vol. 27 ›› Issue (9): 798-800.doi: 10.3969/j.issn.1005-6483.2019.09.025

• 论著 • 上一篇    下一篇

索利那新对膀胱过度活动症病人逼尿肌功能及预后的影响

  

  1. 四川省南部县人民医院泌尿外科
  • 出版日期:2019-09-20 发布日期:2019-09-20

Effect of Solifenacin on detrusor function and prognosis in patients with overactive bladder

  • Online:2019-09-20 Published:2019-09-20

摘要: 目的:探究索利那新对膀胱过度活动症(overactive bladder,OAB)病人逼尿肌功能及预后的影响。方法:OAB病人128例,根据不同的治疗方法分为对照组与研究组,每组各64例。对照组采用托特罗定治疗,研究组采用索利那新治疗,服药时间为8周。比较两组病人尿动力参数、膀胱过度活动症症状评分(overactive bladder symptom score,OABSS)以及不良反应情况。结果:研究组服药后膀胱顺应性、逼尿无抑制收缩次数、膀胱初次排尿感、最大膀胱容量、最大尿流率分别为(53.1±26.4)ml/cm H2O、(1.5±1.2)次、(177.0±88.0)ml、(298.0±88.0)ml和(53.4±17.1)ml/s,对照组分别为(58.2±29.5)ml/cm H2O、(1.9±1.5)次、(155.0±90.0)ml、(275.0±98.0)ml和(54.0±20.1)ml/s,两组比较差异有统计学意义(P<0.05)。研究组和对照组服药后OABSS评分分别为(5.9±2.4)分和(6.7±3.4)分,差异有统计学意义(P<0.05)。研究组不良发生率为4.6%,对照组为14.0%,差异有统计学意义(P<0.05)。结论:索利那新对治疗OAB,临床效果满意,不良反应轻微。

关键词: 索利那新, 托特罗定, 膀胱过度活动症, 逼尿肌功能, 不良反应

Abstract: Objective:To investigate the effect of Solifenacin on detrusor function and prognosis in patients with overactive bladder.Methods:128 cases of patients with overactive bladder admitted to our hospital from March 2016 to December 2018 were selected,and 64 cases were divided into control group and research group according to different treatment methods.The control group was treated with trotrodine and the research group with Solifenacin.The clinical efficacy of the two groups was compared and analyzed.Results:The bladder compliance of the study group,the number of bladder compression inhibition,the initial bladder urination,the maximum bladder volume,and the maximum urine flow rate[(53.1±26.4)ml/cm H2O,(1.5±1.2)times,(177.0±88.0)ml,(298.0±88.0)ml,(53.4±17.1)ml/s]was significantly better than the control group[(58.2±29.5)ml/cm H2O,(1.9±1.5)times,(155.0±90.0)ml,(275.0±98.0)ml,(54.0±20.1)ml/s,and the difference was statistically significant(P<0.05).The OABSS score(5.9±2.4)scores of the study group before and after medication were better than the control group(6.7±3.4),and the difference was statistically significant(P<0.05).The incidence of adverse events in the study group was 4.6% significantly lower than that in the control group(14.0%),and the difference was statistically significant(P<0.05).Conclusion:The use of solifenacin for the treatment of OAB patients,the clinical results are satisfactory,the adverse reactions are mild,it is worthy of clinical use.

Key words: Solifenacin, Tolterodine, overactive bladder, detrusor function, adverse reaction

[1] 丰水强 杨为民 袁晓奕等. 感觉性受体TRPV1在女性膀胱过度活动症患者膀胱尿路上皮中的表达及临床意义 [J]. 临床外科杂志, 2013, 21(5): 372-374.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 李绍春, 涂彦渊, 唐健雄. 机器人手术时代对疝外科的挑战[J]. 临床外科杂志, 2019, 27(9): 731 -733 .
[2] 秦昌富, 陈杰, 申英末等. 中国疝病注册登记随访系统对我国疝和腹壁外科的推动作用[J]. 临床外科杂志, 2019, 27(9): 734 -736 .
[3] 李健文, 唐健雄. 疝外科缝合技术与缝合材料选择中国专家共识(2018版)解读[J]. 临床外科杂志, 2019, 27(9): 737 -739 .
[4] 顾岩, 杨建军, 宋致成等. 腹壁疝组织结构分离技术的进展和改革[J]. 临床外科杂志, 2019, 27(9): 739 -742 .
[5] 闵凯, 吴彪. 复杂腹壁疝修补手术的选择和技术改进前景[J]. 临床外科杂志, 2019, 27(9): 743 -744 .
[6] 陈双, 周太成. 食管裂孔疝解剖学观点[J]. 临床外科杂志, 2019, 27(9): 745 -747 .
[7] 罗文, 段鑫, 柯文杰等. 疝修补术后慢性疼痛的临床特征和诊断治疗[J]. 临床外科杂志, 2019, 27(9): 748 -750 .
[8] 刘鹭, 穆磊, 周毅. 腹股沟疝无张力修补术后补片感染的诊疗分析[J]. 临床外科杂志, 2019, 27(9): 751 -753 .
[9] 陈华涛, 邵永胜, 李晓辉等. 伴有同侧全髋关节置换手术史的腹股沟疝手术术式的选择[J]. 临床外科杂志, 2019, 27(9): 754 -756 .
[10] 王波:彭美红:江海等. 腹腔镜治疗成人Morgagni疝致肠梗阻一例[J]. 临床外科杂志, 2019, 27(9): 756 -757 .